Month: September 2026
-
China’s top court reinforces human-inventor rule, scope of human-contribution standard likely to be tested in future litigation
China’s top court has reissued the rule that AI itself cannot be an inventor and expressly requires a natural person to make a creative contribution to an AI-assisted invention, bringing an approach already taken by the CNIPA into the judicial framework.
-
Honor acquires LG video and image coding portfolio, expands its presence in SEP landscape
The Chinese mobile device brand has also recently become a licensor to Avanci’s vehicle cellular programs, and a licensee to Access Advance’s VVC pool.
-
Simultaneous Great Wall Motor settlements suggest Avanci license: who are the other 6 licensees among China’s top 10 car exporters?
IP Bridge and Sun Patent Trust withdrew their Brazilian cases against GWM on the same day. Previously, Geely and BYD settled. We’ve looked into who the other Chinese Avanci licensees might be.
-
Abbott wins another UPC PI against glucose sensor rival Sibio
The UPC’s Milan Local Division has granted Abbott a second UPC-wide preliminary injunction in its patent infringement case against Chinese rival Sibio, despite allowing the latter’s late-presented claim construction arguments to be admitted.
-
Apple sued by BASF spin-off over face recognition tech in Western District of Texas
Plaintiff trinamiX was established by BASF to commercialize discoveries around advanced sensing, including optical skin recognition.
-
UPC Roundup (1 week): CoA limits evidence-preservation questioning; Dusseldorf LD extends injunction to UK; and more
This is a summary of developments in and around the UPC in the calendar week of August 31, 2026.
-
EPO Enlarged Board limits mandatory description amendments in G 1/25
The EPO Enlarged Board of Appeal has ruled that amended claims do not automatically require corresponding changes to the description, while reinforcing the description’s role in claim interpretation.
-
Podcast: interview with WIPO’s Heike Wollgast on SEP mediation pledge, role of alternative dispute resolution in patent litigation
In our latest podcast episode, ip fray interviewed Heike Wollgast, who heads up the IP Disputes Section of the World Intellectual Property Organization’s Arbitration and Mediation Center.
-
From portfolio growth to commercial value: the next stage of Türkiye’s patent growth
Following the 31% rise in Türkiye’s domestic patent filings, we analyze the shift from portfolio growth toward commercially valuable patents, the limits on international filings, and the country’s emerging SEP capabilities with Vestel IP head Kemal Aygör.
-
Accord slapped with injunction in Munich after invalidity losses in EPO, German Federal Patent Court
The Munich I Regional Court has found that Accord infringed TOWA’s dabigatran etexilate patent, issuing an injunction against the company. Dabigatran etexilate is an oral anticoagulant medicine that stops blood clots from forming, preventing strokes, deep vein thrombosis, and pulmonary embolism, among other things.